Metabolic response at repeat PET/CT predicts pathological response to neoadjuvant chemotherapy in oesophageal cancer.

Metabolic response at repeat PET/CT predicts pathological response to neoadjuvant chemotherapy in oesophageal cancer.

Показать другие версии (1)

OBJECTIVES: Reports have suggested that a reduction in tumour 18F-fluorodeoxyglucose (FDG) uptake on positron emission tomography (PET) examination during or after neoadjuvant chemotherapy may predict pathological response in oesophageal cancer. Our aim was to determine whether metabolic response pr...

Полное описание

Библиографические подробности
Главные авторы:	Gillies, R, Middleton, MR, Blesing, C, Patel, K, Warner, N, Marshall, R, Maynard, N, Bradley, K, Gleeson, F
Формат:	Journal article
Язык:	English
Опубликовано:	2012

Схожие документы

Metabolic response at repeat PET/CT predicts pathological response to neoadjuvant chemotherapy in oesophageal cancer
по: Gillies, R, и др.
Опубликовано: (2012)

Challenges in assessing response of oesophageal cancer to neoadjuvant therapy, and the potential of composite PET-CT and multimodal metrics.
по: Findlay, J, и др.
Опубликовано: (2017)

Role of positron emission tomography-computed tomography in predicting survival after neoadjuvant chemotherapy and surgery for oesophageal adenocarcinoma.
по: Gillies, R, и др.
Опубликовано: (2012)

Role of positron emission tomography-computed tomography in predicting survival after neoadjuvant chemotherapy and surgery for oesophageal adenocarcinoma
по: Gillies, R, и др.
Опубликовано: (2012)

Metabolic nodal response as a prognostic marker after neoadjuvant therapy for oesophageal cancer.
по: Findlay, J, и др.
Опубликовано: (2017)

Tumour expression of the DNA repair protein, XPF, predicts pathological response to neoadjuvant oxaliplatin chemotherapy in oesophageal cancer
по: Gillies, R, и др.
Опубликовано: (2011)

Additional benefit of ¹⁸F-fluorodeoxyglucose integrated positron emission tomography/computed tomography in the staging of oesophageal cancer.
по: Gillies, R, и др.
Опубликовано: (2011)

Additional benefit of 18F-fluorodeoxyglucose integrated positron emission tomography/computed tomography in the staging of oesophageal cancer
по: Gillies, R, и др.
Опубликовано: (2010)

Predicting pathological response of esophageal cancer to neoadjuvant chemotherapy: the implications of metabolic nodal response for personalised therapy
по: Findlay, J, и др.
Опубликовано: (2016)

Role of adjuvant radiotherapy following neo-adjuvant chemotherapy (NACT) and surgery in oesophageal cancer - a multi-centre retrospective cohort study
по: Teoh, S, и др.
Опубликовано: (2016)

The role of 18F-FDG PET/CT in the evaluation of oesophageal carcinoma.
по: Chowdhury, F, и др.
Опубликовано: (2008)

Neoadjuvant chemotherapy for oesophageal carcinoma - a risk factor for postoperative pneumonia?
по: Millo, J, и др.
Опубликовано: (2003)

Differential clonal evolution in oesophageal cancers in response to neo-adjuvant chemotherapy
по: Findlay, J, и др.
Опубликовано: (2016)

Survival after curative chemoradiotherapy or neoadjuvant therapy and surgery converges in higher-risk patients with oesophageal cancer
по: Rana, M, и др.
Опубликовано: (2021)

Impact on postoperative complications of changes in skeletal muscle mass during neoadjuvant chemotherapy for gastro‐oesophageal cancer
по: den Boer, RB, и др.
Опубликовано: (2020)

Differential clonal evolution in oesophageal cancers in response to neo-adjuvant chemotherapy
по: John M. Findlay, и др.
Опубликовано: (2016-04-01)

A reply to evidence-based radiation oncology: oesophagus.
по: Gillies, R, и др.
Опубликовано: (2010)

A DNA-damage immune response assay combined with PET biomarkers predicts response to neo-adjuvant chemotherapy and survival in oesophageal adenocarcinoma
по: Kieran G. Foley, и др.
Опубликовано: (2021-06-01)

Adjuvant radiotherapy following neo-adjuvant chemotherapy and surgery in oesophageal cancer: a retrospective cohort study of survival
по: Teoh, S, и др.
Опубликовано: (2018)

Assessment of Tumor Response to Neoadjuvant Chemotherapy in Breast Cancer Using MRI and 18F FDG PET/CT
по: Reem Yusuf AlBuainain, и др.
Опубликовано: (2025-01-01)

Role of F-18 FDG PET/CT in Predicting Response to Neoadjuvant Chemotherapy in Invasive Ductal Breast Cancer
по: Tarik Sengoz, и др.
Опубликовано: (2023-04-01)

PET/CT staging and response evaluation of post-transplantation lymphoproliferative disease (PTLD).
по: Chowdhury, F, и др.
Опубликовано: (2009)

Propensity score regression analysis of oesophageal adenocarcinoma treatment with surgery alone or neoadjuvant chemotherapy
по: A. G. M. T. Powell, и др.
Опубликовано: (2020-08-01)

Monitoring tumor response to neoadjuvant chemotherapy using MRI and 18F-FDG PET/CT in breast cancer subtypes.
по: Alexander M Th Schmitz, и др.
Опубликовано: (2017-01-01)

Direct comparison of PET/CT and MRI to predict the pathological response to neoadjuvant chemotherapy in breast cancer: a meta-analysis
по: Lihua Chen, и др.
Опубликовано: (2017-08-01)

Immune activation by DNA damage predicts response to chemotherapy and survival in oesophageal adenocarcinoma
по: Turkington, RC, и др.
Опубликовано: (2019)

Routinely staging gastric cancer with 18F-FDG PET-CT detects additional metastases and predicts early recurrence and death after surgery
по: Findlay, J, и др.
Опубликовано: (2019)

Clinical value of SUVpeak-to-tumor centroid distance on FDG PET/CT for predicting neoadjuvant chemotherapy response in patients with breast cancer
по: Sun-pyo Hong, и др.
Опубликовано: (2024-10-01)

Whole transcriptome analysis of breast tumors during neoadjuvant chemotherapy: association with response to preoperative chemotherapy
по: M. K. Ibragimova, и др.
Опубликовано: (2022-03-01)

Prognostic value of 18F-FDG PET and PET/CT for assessment of treatment response to neoadjuvant chemotherapy in breast cancer: a systematic review and meta-analysis
по: Sangwon Han, и др.
Опубликовано: (2020-10-01)

Efficacy Of 18FDG-PET/CT In Predicting Response After Neoadjuvant Chemoradiation In Rectal Cancer
по: Narendra Pandit, и др.
Опубликовано: (2023-08-01)

Comparison between body composition parameters and response to neoadjuvant chemotherapy by using pre-treatment PET CT in locally advanced breast cancer
по: Inci Kizildag Yirgin, и др.
Опубликовано: (2020-01-01)

The Role of Pretreatment 18F-FDG PET/CT for Early Prediction of Neoadjuvant Chemotherapy Response in Patients with Locoregionally Advanced Nasopharyngeal Carcinoma
по: Yao J, и др.
Опубликовано: (2021-10-01)

Whole transcriptome analysis of breast tumors during neoadjuvant chemotherapy: association with response to preoperative chemotherapy. Additional material
по: M. K. Ibragimova, и др.
Опубликовано: (2022-03-01)

Neoadjuvant camrelizumab plus chemotherapy in locally advanced oesophageal squamous cell carcinoma: a retrospective cohort study
по: Rui-Qin Zhou, и др.
Опубликовано: (2023-05-01)

[18F]FDG PET/CT for evaluating early response to neoadjuvant chemotherapy in pediatric patients with sarcoma: a prospective single-center trial
по: Giulia Polverari, и др.
Опубликовано: (2020-10-01)

Correlation Between 18F-FDG PET/CT SUVmax and Clinicopathological Features, Neoadjuvant Chemotherapy Response in Invasive Ductal Breast Carcinoma Patients
по: LU Shengnan, и др.
Опубликовано: (2019-02-01)

Poor response to neoadjuvant chemotherapy in metaplastic breast carcinoma
по: Willard Wong, и др.
Опубликовано: (2021-07-01)

EVALUATİON OF RESPONSE TO NEOADJUVANT CHEMOTHERAPY İN PATİENTS WİTH BREAST CANCER
по: Can Atalay, и др.
Опубликовано: (2007-01-01)

MOLECULAR-GENETIC MARKERS OF RESPONSE TO NEOADJUVANT CHEMOTHERAPY WITH ANTHRACYCLINES IN BREAST CANCER PATIENTS
по: P. V. Kazantseva, и др.
Опубликовано: (2016-07-01)